Thermo Fisher Scientific Releases Watson LIMS 7.4, Delivering Time and Cost Savings to the Bioanalytical Laboratory's Workflow

Philadelphia/Pennsylvania, (PresseBox) - Thermo Fisher Scientific Inc., the world leader in serving science, introduces new functionality to the latest release of its Thermo Scientific Watson LIMS (Laboratory Information Management System) that brings critical time and cost savings to pharmaceutical companies and contract research organizations (CROs) involved in drug metabolism and pharmacokinetic (DMPK) studies for drug discovery and development. The latest release of Watson LIMS, the leading bioanalytical laboratory information management system, delivers improved efficiencies and reduced validation time, contributing to time and cost savings and improved time to market.

Of the many new features unique to Watson LIMS, key among them is the new functionality in Watson 7.4 that simplifies daily workflow for bioanalytical laboratories by delivering enhanced functionality for incurred sample reanalysis (ISR). ISR has become an accepted way to assess the quality of bioanalytical assays and is widely accepted within the pharmaceutical industry and by regulatory agencies. The latest release of Watson LIMS allows researchers to perform incurred sample reanalysis on an individual sample basis, and eliminates the previously required mandatory repeat runs for bioanalytical samples. Watson's new ISR reporting features provide new comparison methods with built-in calculations and greater ease of use by enabling flexible, pre-configured reporting of ISR results using templates, for a truly out-of-the-box user experience.

Additional new functionality enhancements to Watson 7.4 include performance enhancements in the Design Summary Report, delivering a dramatic increase in reporting speed, enhancements to the Immune Response Module and the Watson Web Services Library, enabling users to more easily manage the status of samples, choose samples with a Positive Screen or a Positive Titer result for use in subsequent assay tests, and import samples and sample-related information from external applications.

Thermo Scientific Watson LIMS v. 7.4 also includes an industry-first built-in data interchange with the company's TSQ Series mass spectrometers, allowing for direct data acquisition, peak integration and re-integration, storage, archiving and reporting of raw data, all under the control of Watson's centralized Oracle® database repository. Watson's connectivity to Thermo Scientific TSQ Series mass spectrometers eliminates time-consuming manual verification of LC/MS data transfers, and provides a single audit trail for QA and the FDA, providing greater workflow efficiencies, time and cost savings. This end-to-end solution delivers greatly enhanced functionality for data security and chain of custody for regulatory compliance, as well as a lower cost of ownership due to the reduced validation burden. Watson's direct data acquisition from Thermo Scientific TSQ Series LC/MS instruments, together with its new incurred sample reanalysis functionality and reporting delivers time savings to pharmaceutical companies and CROs, allowing them to bring drugs to market faster for less cost.

Thermo Scientific Watson LIMS is the leading bioanalytical LIMS, relied upon by 18 of the top 20 pharmaceutical companies as well as leading CROs worldwide. Watson is a highly specialized, protocol-driven software application designed to support drug metabolism and pharmacokinetic (DMPK) studies in drug discovery and development. Pharmaceutical companies and CROs worldwide that standardize on Thermo Scientific Watson LIMS can count on secure data transmissions, regulatory compliance, reliable audit trails and improved time to market.

Thermo Fisher Scientific will exhibit Watson LIMS v. 7.4 at the Annual Conference of the American Society for Mass Spectrometry (ASMS) in Philadelphia from May 31 - June 4th, as well as a wide range of industry-leading instrumentation and services designed to simplify complex workflows and processes so customers can focus on moving science forward.

Oracle® is a registered trademark of Oracle Corporation and/or its affiliates.

Fisher Scientific GmbH (Thermo Fisher Scientific)

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With 2008 revenues of $10.5 billion, we have approximately 34,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. The Thermo Scientific brand represents a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit

Press releases you might also be interested in

Weitere Informationen zum Thema "Hardware":

Huawei setzt auf NVMe für eine intensive I/O-Zukunft

Nur we­ni­ge Tech­no­lo­gi­en ha­ben sich so er­folg­reich in un­ter­neh­mens­wei­ten IT-St­ra­te­gi­en durch­ge­setzt wie die All-Flash-Ar­rays (AFAs), die da­bei zwei Jahr­zehn­te eta­b­lier­ter SAS- und SA­TA-Fest­plat­ten­tech­no­lo­gi­en ver­drängt ha­ben.


Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.

I want to subscribe to the gratis press mail and have read and accepted the conditions.